Development of potent and selective tetrahydro-β-carboline-based HDAC6 inhibitors with promising activity against triple-negative breast cancer.
开发高效且选择性的四氢-β-咔啉类HDAC6抑制剂，对三阴性乳腺癌具有良好的活性
期刊:RSC Medicinal Chemistry
影响因子:3.6
doi:10.1039/d5md00086f
Fathy Aya, Allam Amro, ElHady Ahmed K, El-Gamil Dalia S, Lin Kai-Chun, Chang Yen-Hua, Lee Yu-Hsuan, Hilscher Sebastian, Schutkowski Mike, Ibrahim Hany S, Chen Shun-Hua, Chen Chun-Hong, Abadi Ashraf H, Sippl Wolfgang, Chen Po-Jen, Cheng Yi-Sheng, Abdel-Halim Mohammad
